C. STOCKHOLDERS EQUITY (Tables)

3 Months Ended

Dec. 31, 2014

C. Stockholders Equity Tables

Stock options, stock bonuses and compensation granted by the Company

Name of Plan	Total Shares Reserved Under Plans		Shares Reserved for Outstanding Options		Shares Issued as Stock Bonus		Remaining Options/Shares Under Plans
Incentive Stock Options Plans		1,960,000		1,710,997		N/A		3,303
Non-Qualified Stock Option Plans		5,680,000		5,023,652		N/A		99,429
Stock Bonus Plans		1,594,000		N/A		1,162,612		430,632
Stock Compensation Plan		1,350,000		N/A		1,316,949		33,051
Incentive Stock Bonus Plan		16,000,000		N/A		15,700,000		300,000

Schedule of employees and non-employees stock compensation

	Three Months Ended December 31,
	2014		2013
Employees	$	3,059,791	$	510,278
Non-employees	$	189,144	$	214,720

Derivative Liabilities, Warrants and Other Options

Warrant	Issue Date	Shares Issuable upon Exercise of Warrant		Exercise Price		Expiration Date	Reference
Schleuning (Series A)	7/8/09		16,750		5.00	1/8/15		1
Series C	8/20/09 – 8/26/09		463,487		5.50	2/20/15		1
Series H	1/26/12		1,200,000		5.00	8/1/15		1
Series Q	6/21/12		1,200,000		5.00	12/22/15		1
Series R	12/6/12		2,625,000		4.00	12/6/16		1
Series S	10/11/13- 10/24/14		25,928,010		1.25	10/11/18		1
Series U	4/17/14		445,514		1.75	10/17/17		1
Series L (repriced)	4/18/07		70,000		2.50	4/2/15		2
Series N	8/18/08		2,844,627		0.53	8/18/15		2
Series P	2/10/12		590,001		4.50	3/6/17		2
Warrants held by Officer and Director	7/6/09		184,930		5.00	1/6/15		2
Consultants	2/15/05– 4/25/14		149,500		0.85-20.00	2/15/15 - 12/27/17		3

Tabular disclosure of derivative liabilities at fair value

The table below presents the derivative instruments outstanding at the balance sheet dates and their respective balances:

	December 31, 2014		September 30, 2014
Series A through E warrants	$	-	$	6,105
Series H warrants		12,000		12,000
Series Q warrants		12,000		12,000
Series R warrants		26,250		157,500
Series S warrants		3,707,706		5,197,352
Series U warrants		45,057		120,289
Total derivative liabilities	$	3,803,013	$	5,505,246

Tabular disclosure of gains and (losses) of derivative liabilities

The table below presents the gains and (losses) on the derivative instruments for the three months ended December 31:

	2014		2013
Series A through E warrants	$	6,105	$	-
Series H warrants		-		24,000
Series N warrants		-		(489,754	)
Series Q warrants		-		24,000
Series R warrants		131,250		131,250
Series S warrants		1,950,383		1,921,321
Series U warrants		75,232		-
Net gain on derivative instruments	$	2,162,970	$	1,610,817